三亚佐拉姆 (Triazolam) 是一种药物.

R F Drucker, N MacLeod

Lancet (London, England)

|September 16, 1989

概括

No abstract available in PubMed .

相关概念视频

您也可能阅读

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

GLP-1 receptor agonist use for obesity in service personnel.

BMJ military health·2025

Same author

Pain management in patients with malignant mesothelioma: challenges and solutions.

Lung Cancer (Auckland, N.Z.)·2019

Same author

Towards the automated identification of Chrysomya blow flies from wing images.

Medical and veterinary entomology·2018

Same author

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.

Clinical and translational radiation oncology·2018

Same author

A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.

British journal of cancer·2015

Same author

Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery.

The Journal of physiology·2014

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

查看所有相关文章

相关实验视频

三亚佐拉姆 (Triazolam) 是一种药物.

相关概念视频

GLP-1 receptor agonist use for obesity in service personnel.

Pain management in patients with malignant mesothelioma: challenges and solutions.

Towards the automated identification of Chrysomya blow flies from wing images.

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.

A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.

Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

相关实验视频

三亚佐拉姆 (Triazolam) 是一种药物.

相关概念视频

GLP-1 receptor agonist use for obesity in service personnel.

Pain management in patients with malignant mesothelioma: challenges and solutions.

Towards the automated identification of Chrysomya blow flies from wing images.

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma.

A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.

Influence of high altitude on cerebral blood flow and fuel utilization during exercise and recovery.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.